<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:46:20Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/11372" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/11372</identifier><datestamp>2026-09-24T20:53:20Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Larche, Mark</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Nair, Parameswaran</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Mark Inman, Frederick Hargreave</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Simms, Elizabeth</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T16:54:27Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T16:54:27Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2011-09-28</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2011-10</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/6343</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">7361</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">2262257</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/11372</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/13735</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>Asthma is a lung disease characterized by wide variations in airflow over short periods of time. Exacerbations of asthma can be accompanied by symptoms of chest tightness, shortness of breath and wheezing; airway inflammation characterized by an influx of eosinophils and/or neutrophils; and the expression of pro-inflammatory cytokines in the airway. There is strong evidence supporting a central role for the T cell in asthma. In atopic asthma, T cells are documented components of the late-phase response to inhaled allergen, driving airway inflammation, mucus hypersecretion, and bronchoconstriction through the release of cytokines and other mediators. T cells have also been shown to produce inflammatory cytokines in response to allergen in nonatopic asthmatics, indicating a potential role in mediating disease in this phenotype. In both atopic and nonatopic asthma, aberrant T cell responses to allergen may drive the infiltration of neutrophils and eosinophils into the airway through the production of pro- inflammatory cytokines, leading to exacerbations of disease. This project has investigated the role of several T cell cytokines in driving disease and acting as biomarkers in asthma: interleukin-5, interleukin-17A, interleukin-23, interleukin- 10, and interferon-γ. We have measured allergen-induced cytokine production by peripheral blood mononuclear cells (PBMCs) and examined its ability to distinguish between different asthma phenotypes: asthma vs normal, atopic vs nonatopic asthma, eosinophilic bronchitis vs noneosinophilic bronchitis, and neutrophilic vs nonneutrophilic bronchitis. Our data shows that allergen-induced peripheral blood mononuclear cell responses to allergen are not good biomarkers of disease in asthma. No differences in PBMC cytokine production are seen in patients with asthma, compared with normal controls, or between patients with different asthmatic phenotypes. It is not possible to determine a patient’s disease state, atopic status, or type of bronchitis by examining their PBMC cytokine responses to allergen.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">asthma</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">atopic asthma</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">nonatopic asthma</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">cytokines</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Allergy and Immunology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Allergy and Immunology</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Cytokines as Biomarkers in Asthma</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>